Compounds > pd 98059

pd 98059 and lipoxin a4

pd 98059 has been researched along with lipoxin a4 in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barja-Fidalgo, C; da-Fé, AR; Fierro, IM; Niconi-de-Almeida, Y; Simões, RL1
Cai, L; Hao, H; Li, HH; Miao, S; Tang, K; Wu, L; Wu, P; Wu, Q; Xiong, J; Ye, DY; Zeng, P; Zou, LB1
Buchanan, PJ; Harvey, BJ; McNally, P; Urbach, V1

Other Studies

3 other study(ies) available for pd 98059 and lipoxin a4

ArticleYear
A synthetic analog of 15-epi-lipoxin A4 inhibits human monocyte apoptosis: involvement of ERK-2 and PI3-kinase.
    Prostaglandins & other lipid mediators, 2010, Volume: 91, Issue:1-2

    Topics: Active Transport, Cell Nucleus; Animals; Apoptosis; bcl-2-Associated X Protein; Cell Survival; Chromones; Dose-Response Relationship, Drug; Enzyme Activation; Flavonoids; Humans; Inflammation; Lipoxins; Mitochondria; Mitogen-Activated Protein Kinase 1; Monocytes; Morpholines; Phosphatidylinositol 3-Kinases; Phosphorylation; Proto-Oncogene Proteins c-akt; Receptors, G-Protein-Coupled

2010
Lipoxin A4 inhibits 5-lipoxygenase translocation and leukotrienes biosynthesis to exert a neuroprotective effect in cerebral ischemia/reperfusion injury.
    Journal of molecular neuroscience : MN, 2012, Volume: 48, Issue:1

    Topics: Animals; Animals, Newborn; Arachidonate 5-Lipoxygenase; Astrocytes; Brain Edema; Brain Ischemia; Disease Models, Animal; Enzyme Inhibitors; Flavonoids; Glucose; Leukotriene B4; Leukotriene C4; Leukotrienes; Lipoxins; Male; MAP Kinase Signaling System; Neuroprotective Agents; Oxygen; Rats; Rats, Sprague-Dawley; Reperfusion Injury; RNA, Messenger

2012
Lipoxin A₄-mediated KATP potassium channel activation results in cystic fibrosis airway epithelial repair.
    American journal of physiology. Lung cellular and molecular physiology, 2013, Jul-15, Volume: 305, Issue:2

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Cell Line, Transformed; Cell Proliferation; Cystic Fibrosis; Epithelial Cells; Flavonoids; Glyburide; Humans; Hypoglycemic Agents; KATP Channels; Lipoxins; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Phosphorylation; Protein Kinase Inhibitors; Receptors, Formyl Peptide; Receptors, Lipoxin; Respiratory Mucosa

2013